981 related articles for article (PubMed ID: 31444473)
21. Modeling cell-cell interactions in the brain using cerebral organoids.
Oliveira B; Çerağ Yahya A; Novarino G
Brain Res; 2019 Dec; 1724():146458. PubMed ID: 31521639
[TBL] [Abstract][Full Text] [Related]
22. Transcriptomic Mapping of Neural Diversity, Differentiation and Functional Trajectory in iPSC-Derived 3D Brain Organoid Models.
Kiaee K; Jodat YA; Bassous NJ; Matharu N; Shin SR
Cells; 2021 Dec; 10(12):. PubMed ID: 34943930
[TBL] [Abstract][Full Text] [Related]
23. Modeling neurological disorders using brain organoids.
Zhang DY; Song H; Ming GL
Semin Cell Dev Biol; 2021 Mar; 111():4-14. PubMed ID: 32561297
[TBL] [Abstract][Full Text] [Related]
24. Concise Review: Modeling Neurodegenerative Diseases with Human Pluripotent Stem Cell-Derived Microglia.
Haenseler W; Rajendran L
Stem Cells; 2019 Jun; 37(6):724-730. PubMed ID: 30801863
[TBL] [Abstract][Full Text] [Related]
25. Modeling Alzheimer's Disease Using Human Brain Organoids.
Karmirian K; Holubiec M; Goto-Silva L; Fernandez Bessone I; Vitória G; Mello B; Alloatti M; Vanderborght B; Falzone TL; Rehen S
Methods Mol Biol; 2023; 2561():135-158. PubMed ID: 36399268
[TBL] [Abstract][Full Text] [Related]
26. Use of 3D Organoids as a Model to Study Idiopathic Form of Parkinson's Disease.
Chlebanowska P; Tejchman A; Sułkowski M; Skrzypek K; Majka M
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31973095
[TBL] [Abstract][Full Text] [Related]
27. Human Brain Organoid: A Versatile Tool for Modeling Neurodegeneration Diseases and for Drug Screening.
Ma C; Seong H; Li X; Yu X; Xu S; Li Y
Stem Cells Int; 2022; 2022():2150680. PubMed ID: 36061149
[TBL] [Abstract][Full Text] [Related]
28. Harnessing cerebral organoids for Alzheimer's disease research.
Bubnys A; Tsai LH
Curr Opin Neurobiol; 2022 Feb; 72():120-130. PubMed ID: 34818608
[TBL] [Abstract][Full Text] [Related]
29. Modelling Alzheimer's disease: Insights from in vivo to in vitro three-dimensional culture platforms.
Ranjan VD; Qiu L; Tan EK; Zeng L; Zhang Y
J Tissue Eng Regen Med; 2018 Sep; 12(9):1944-1958. PubMed ID: 30011422
[TBL] [Abstract][Full Text] [Related]
30. The Use of Pluripotent Stem Cell-Derived Organoids to Study Extracellular Matrix Development during Neural Degeneration.
Yan Y; Bejoy J; Marzano M; Li Y
Cells; 2019 Mar; 8(3):. PubMed ID: 30875781
[TBL] [Abstract][Full Text] [Related]
31. Concise Review: Current Status of Three-Dimensional Organoids as Preclinical Models.
Kaushik G; Ponnusamy MP; Batra SK
Stem Cells; 2018 Sep; 36(9):1329-1340. PubMed ID: 29770526
[TBL] [Abstract][Full Text] [Related]
32. Advancing Drug Discovery for Neurological Disorders Using iPSC-Derived Neural Organoids.
Costamagna G; Comi GP; Corti S
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800815
[TBL] [Abstract][Full Text] [Related]
33. What Have Organoids and Assembloids Taught Us About the Pathophysiology of Neuropsychiatric Disorders?
Levy RJ; Paşca SP
Biol Psychiatry; 2023 Apr; 93(7):632-641. PubMed ID: 36739210
[TBL] [Abstract][Full Text] [Related]
34. Disease Modeling in Stem Cell-Derived 3D Organoid Systems.
Dutta D; Heo I; Clevers H
Trends Mol Med; 2017 May; 23(5):393-410. PubMed ID: 28341301
[TBL] [Abstract][Full Text] [Related]
35. Modeling neurodegenerative diseases with patient-derived induced pluripotent cells: Possibilities and challenges.
Poon A; Zhang Y; Chandrasekaran A; Phanthong P; Schmid B; Nielsen TT; Freude KK
N Biotechnol; 2017 Oct; 39(Pt B):190-198. PubMed ID: 28579476
[TBL] [Abstract][Full Text] [Related]
36. Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids.
Mun SJ; Ryu JS; Lee MO; Son YS; Oh SJ; Cho HS; Son MY; Kim DS; Kim SJ; Yoo HJ; Lee HJ; Kim J; Jung CR; Chung KS; Son MJ
J Hepatol; 2019 Nov; 71(5):970-985. PubMed ID: 31299272
[TBL] [Abstract][Full Text] [Related]
37. Organoids: the third dimension of human brain development and disease.
Kouroupi G; Prodromidou K; Papastefanaki F; Taoufik E; Matsas R
Int J Dev Biol; 2022; 66(1-2-3):23-33. PubMed ID: 34881786
[TBL] [Abstract][Full Text] [Related]
38. Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models.
Logan S; Arzua T; Canfield SG; Seminary ER; Sison SL; Ebert AD; Bai X
Compr Physiol; 2019 Mar; 9(2):565-611. PubMed ID: 30873582
[TBL] [Abstract][Full Text] [Related]
39. Combining Automated Organoid Workflows with Artificial Intelligence-Based Analyses: Opportunities to Build a New Generation of Interdisciplinary High-Throughput Screens for Parkinson's Disease and Beyond.
Renner H; Schöler HR; Bruder JM
Mov Disord; 2021 Dec; 36(12):2745-2762. PubMed ID: 34498298
[TBL] [Abstract][Full Text] [Related]
40. Micro/nano devices for integration with human brain organoids.
Tran HN; Gautam V
Biosens Bioelectron; 2022 Dec; 218():114750. PubMed ID: 36244136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
